Concepts in radioimmunotherapy and immunotherapy: Radioimmunotherapy from a Lym-1 perspective

被引：14

作者：

DeNardo, GL ^{[1
]}

机构：

[1] Univ Calif Davis, Med Ctr, Div Hematol Oncol, Sacramento, CA 95816 USA

来源：

SEMINARS IN ONCOLOGY | 2005年 / 32卷 / 01期

关键词：

D O I：

10.1053/j.seminoncol.2005.01.011

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：S27 / S35

页数：9

共 53 条

[1]

ARMITAGE JO, 1993, NEW ENGL J MED, V328, P1023

[2]

The relationship between Bcl2, Bax and p53: consequences for cell cycle progression and cell death [J].

Basu, A ;

Haldar, S .

MOLECULAR HUMAN REPRODUCTION, 1998, 4 (12) :1099-1109

[3]

Bradt BM, 2003, CLIN CANCER RES, V9, p4007S

[4]

DeNardo DA, 1996, J NUCL MED, V37, P1970

[5]

Impact of interpatient pharmacokinetic variability on design considerations for therapy with radiolabeled MAbs [J].

DeNardo, G ;

Yuan, A ;

Goldstein, D ;

Richman, C ;

O'Donnell, R ;

Shen, S ;

Siantar, CH ;

DeNardo, S .

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2003, 18 (02) :231-237

[6]

DeNardo G L, 2000, Clin Lymphoma, V1, P118, DOI 10.3816/CLM.2000.n.010

[7]

DENARDO GL, 1994, CANCER, V73, P1012, DOI 10.1002/1097-0142(19940201)73:3+<1012::AID-CNCR2820731340>3.0.CO

[8]

2-0

[9]

Human antiglobulin response to foreign antibodies: therapeutic benefit? [J].

DeNardo, GL ;

Bradt, BM ;

Mirick, GR ;

DeNardo, SJ .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2003, 52 (05) :309-316

[10]

Radiation dosimetry for radionuclide therapy in a nonmyeloablative strategy [J].

DeNardo, GL ;

Siantar, CLH ;

DeNardo, SJ .

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2002, 17 (01) :107-118

← 1 2 3 4 5 6 →